PHASE-II STUDY OF ORAL VP-16-213 IN SMALL-CELL LUNG-CANCER

被引：0

作者：

MATSUI, Y

OSHIMA, S

KADO, M

NAKAYAMA, M

SHIMOKATA, K

SAKAI, S

ITO, F

CHIKATA, E

HARA, K

KANDA, T

SHIMA, K

TAKENAKA, S

HOKAMA, S

GENGA, K

机构：

[1] NAGOYA 1ST RED CROSS HOSP,DEPT INTERNAL MED,NAGOYA,JAPAN

[2] NATL TONEYAMA HOSP,DEPT INTERNAL MED,TOYONAKA,JAPAN

[3] UNIV RYUKYUS,SCH MED,DEPT CENT CLIN LAB,NAHA,OKINAWA 903,JAPAN

[4] KUMAMOTO MUNICIPAL HOSP,DEPT INTERNAL MED,KUMAMOTO,JAPAN

[5] KYOTO 1ST RED CROSS HOSP,DEPT RESP DIS,KYOTO,JAPAN

[6] NATL OKINAWA HOSP,DEPT SURG,OKINAWA,JAPAN

[7] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 1,NAGOYA,AICHI 464,JAPAN

[8] NAGASAKI UNIV,SCH MED,DEPT INTERNAL MED 2,NAGASAKI 852,JAPAN

来源：

关键词：

D O I：

10.1002/1097-0142(19871215)60:12<2882::AID-CNCR2820601205>3.0.CO;2-A

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2882 / 2885

页数：4

共 14 条

[1] ANDERSON G, 1981, THORAX, V35, P462
[2] ARNOLD AM, 1979, CANCER CHEMOTH PHARM, V3, P71
[3] CAVALLI F, 1978, CANCER TREAT REP, V62, P473
[4] FALKSON G, 1975, CANCER, V35, P1141, DOI 10.1002/1097-0142(197504)35:4<1141::AID-CNCR2820350418>3.0.CO
[5] 2-3
[6] HANSEN M, 1977, CANCER, V40, P633, DOI 10.1002/1097-0142(197708)40:2<633::AID-CNCR2820400207>3.0.CO
[7] 2-O
[8] ETOPOSIDE (VP-16-213)
ISSELL, BF
CROOKE, ST
[J]. CANCER TREATMENT REVIEWS, 1979, 6 (02) : 107 - 124
[9] JUNGI WF, 1975, CANCER CHEMOTH REP 1, V59, P737
[10] LAU ME, 1979, CANCER TREAT REP, V63, P485